In The News Posted November 12, 2021 Share Posted November 12, 2021 HOUSTON, Nov. 12, 2021 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that Walter V. Kemp, Founder,...View the full article Quote Link to comment Share on other sites More sharing options...
Recommended Posts